Studio shot of a mature man looking stressed out against a gray backgroundhttp://195.154.178.81/DATA/istock_collage/a3/shoots/785270.jpg (shapecharge)
Teva Pharmaceutical Industries Ltd said on Wednesday its experimental drug to prevent migraine met the main goal in a late-stage study.
Patients treated with the drug, fremanezumab, experienced a statistically significant reduction in the number of monthly headache days over the 12-week period for both monthly and quarterly dosing regimens, the company said.
Fox News Health
Stay up-to-date on the biggest health and wellness news with our weekly recap.
By entering your email and clicking the Subscribe button, you agree to the Fox News Privacy Policy and Terms of Use, and agree to receive content and promotional communications from Fox News. You understand that you can opt-out at any time.